About
Dani Martin-Herranz, PhD is a biotechnology operator and scientist best identified publicly as Co-founder and Chief Science Officer of Hurdle, a diagnostics company under Chronomics branding. Hurdle says he leads the science team and biomarker R&D, with expertise spanning computational biology, epigenetics, ageing, biomarker discovery, and in vitro diagnostics. His public profile is consistent with a scientific and ecosystem-building role rather than a capital deployment role.
Areas of interest
biotechdiagnosticsprecision medicinebiomarker discoverycomputational biologyepigeneticsageingin vitro diagnosticsmachine learningmulti-omics